Advertisement
Women with screening-detected ductal carcinoma in situ have increased long-term risks for invasive breast cancer and breast cancer death

Risk for Later Invasive Breast Cancer Up for Women With DCIS

0
Risks for invasive breast cancer, death from breast cancer higher for up to 20 years following diagnosis
Hydroxychloroquine and azithromycin may have a serious adverse impact on the cardiovascular system

CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine

0
Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
Large pharmacy chains

Large U.S. Pharmacy Chains Played Role in Opioid Crisis, Lawsuit Claims

0
Lawsuit charges chains sold millions of pills in small communities, gave bonuses to pharmacists
Coronavirus antibody test results may not be accurate enough to help guide decisions about whether to allow large groups of people to gather at work

CDC: Coronavirus Antibody Tests Still Not Accurate Enough

0
Too little is known about what the presence of antibodies means in terms of future immunity
Patients initiating hemodialysis often are prescribed opioids and short-acting benzodiazepines

Benzodiazepines, Codispensed Opioids Common in Hemodialysis

0
Risk for mortality increased for those receiving short-acting benzodiazepines alone or with opioids
For adults hospitalized with COVID-19 with lower respiratory tract infection

Remdesivir Beats Placebo for Time to COVID-19 Recovery

0
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.

WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients

0
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
Reacting to skyrocketing prices for insulin

New Medicare Benefit Would Limit Insulin Copays to $35 a Month

0
Benefit will be voluntary; Medicare recipients must pick an insurance plan that provides it
For patients with advanced-stage pancreatic ductal adenocarcinoma

Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects

0
PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency
A recombinant adenovirus type-5 vectored COVID-19 vaccine is safe

Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise

0
ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28